All In Biotech

Drug Trial Radar · NCT03249480

Pegylated Somatropin (PEG Somatropin) in the Treatment of Children With Growth Hormone Deficiency

Pegylated Somatropin (PEG Somatropin) in the Treatment of Children With Growth Hormone Deficiency: A Multicenter, Open-label, Phase IV Clinical Trial With Different Administration Dosage of PEG Somatropin

Last checked: Nov 19, 2026Latest source record: Aug 15, 2017 (this record)Source: ClinicalTrials.govMethods & limitations

Status unknown

Status

Status unknown

Enrollment

900

Planned (sponsor's estimate)

Start

Jan 2015

Primary completion

Aug 2017

Sponsor

Sponsor type
Industry
Collaborators
Beijing Children's Hospital; Tianjin Medical University General Hospital; Peking University Third Hospital; China-Japan Friendship Hospital; Dalian Children's Hospital; Xian Children's Hospital; Wuhan Children's Hospital; Fuzhou Children s Hospital; Anhui Provincial Children's Hospital; Hunan Children's Hospital; Shenzhen Children's Hospital; Children's Hospital of Hebei Province; Second Affiliated Hospital of Xi'an Jiaotong University; Zhengzhou Children's Hospital, China; Children's Hospital of Soochow University; Maternal and Child Health Hospital of Guangxi Zhuang Autonomous Region; First Affiliated Hospital of Kunming Medical University; Kunming Children's Hospital; The First People's Hospital of Yunnan; Xuzhou Children's Hopspital; Henan Provincial People's Hospital; The First Affiliated Hospital of Henan University of Traditional Chinese Medicine; First Affiliated Hospital of Harbin Medical University; The Second Hospital of Hebei Medical University; Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University; Union Hospital of Tongji Medical College of HUST; Wuxi Women's & Children's Hospital; The Second Affiliated Hospital of Kunming Medical University; Nanjing Children's Hospital
First posted
Aug 15, 2017

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 4
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
All sexes, from 3 years, up to 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

To Evaluate the safety and efficacy of PEG Somatropin in the treatment of children with growth hormone deficiency, as well as to study the dosage of PEG Somatropin.

Conditions

  • Growth Hormone Deficiency

Interventions

  • PEG-somatropinBiological

    30IU/10 mg/3ml/kit, 0.1-0.2mg /kg/w, once per day for 26 weeks.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Ht SDSca (Height Standard Deviation Score for Chronological Age)Time frame: Baseline
  2. Change of yearly growth velocity from baseline to 26 weeksTime frame: Baseline, 26 weeks after initiating treatment
  3. Ht SDScaTime frame: 26 weeks after initiating treatment

Locations

28 sites in 1 country. Site status is shown where the registry gives one.

  • China-Japan Friendship Hospital

    Beijing, China · Recruiting

  • Peking University Third Hospital

    Beijing, China · Recruiting

  • Shenzhen Children's Hospital

    Shenzhen, China · Recruiting

  • Tianjin Medical University General Hospital

    Tianjin, China · Recruiting

  • Anhui Provincial Children's Hospital

    Hefei, Anhui, China · Recruiting

  • Fuzhou Children s Hospital

    Fuzhou, Fujian, China · Recruiting

  • Sun Yat-Sen Memorial Hospital

    Guangzhou, Guangdong, China · Recruiting

  • The Second Hospital of Hebei Medical University

    Shijiangzhuang, Hebei, China · Recruiting

  • Children's Hospital of Hebei Province

    Shijiazhuang, Hebei, China · Recruiting

  • The First Affiliated Hospital of Harbin Medical University

    Harbin, Heilongjiang, China · Recruiting

  • Children's Hospital of Zhengzhou

    Zhengzhou, Henan, China · Recruiting

  • Henan Provincal People's Hospital

    Zhengzhou, Henan, China · Recruiting

  • The First Affiliated Hospital of Henan University of TCM

    Zhengzhou, Henan, China · Recruiting

  • Union Hospital, Tongji Medical College, HUST

    Wuhan, Hubei, China · Recruiting

  • Wuhan Children's Hospital

    Wuhan, Hubei, China · Recruiting

  • Hunan Children's Hospital

    Changsha, Hunan, China · Recruiting

  • Maternal & Child Health Hospital of Guangxi Zhuang Autonomous Region

    Nanjing, Jiangsu, China · Recruiting

  • Nanjing Children's Hospital

    Nanjing, Jiangsu, China · Recruiting

  • Children's Hospital of Soochow University

    Suzhou, Jiangsu, China · Recruiting

  • Wuxi Children's Hospital

    Wuxi, Jiangsu, China · Recruiting

  • Xuzhou Children's Hpspital

    Xuzhou, Jiangsu, China · Recruiting

  • Dalian Children's Hospital

    Dalian, Liaoning, China · Recruiting

  • The Second Affiliated Hospital of Xi'an Jiaotong University

    Xi’an, Shanxi, China · Recruiting

  • Xi'an Children's Hospital

    Xi’an, Shanxi, China · Recruiting

  • First Affiliated Hospital of Kunming Medical University

    Kunming, Yunnan, China · Recruiting

  • Kunming Children's Hospital

    Kunming, Yunnan, China · Recruiting

  • Second Affiliated Hospital of Kunming Medical University

    Kunming, Yunnan, China · Recruiting

  • The First People's Hospital of Yunnan Province

    Kunming, Yunnan, China · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.